Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 13
- No 13F data for Q4 2020
- Portfolio value
- $298.9M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 4,179,416 | $137.5M | 46.0% | – | – | History |
| NGMNGM Biopharmaceuticals Inc | COM | 1,493,349 | $43.4M | 14.5% | – | – | History |
| ORICOric Pharmaceuticals, Inc. | COM | 996,734 | $24.4M | 8.2% | – | – | History |
| ALECAlector, Inc. | COM | 980,894 | $19.8M | 6.6% | – | – | History |
| DNLIDenali Therapeutics Inc. | COM | 323,749 | $18.5M | 6.2% | – | – | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,261,261 | $16.6M | 5.6% | – | – | History |
| RAPTRAPT Therapeutics, Inc. | COM | 735,801 | $16.3M | 5.5% | – | – | History |
| CNSTConstellation Pharmaceuticals Inc | COM | 554,325 | $13.0M | 4.3% | – | – | History |
| FFBCFirst Financial Bancorp | COM | 173,576 | $4.17M | 1.4% | – | – | History |
| BEAMBeam Therapeutics Inc. | COM | 31,131 | $2.49M | 0.8% | – | – | History |
| VIRVir Biotechnology, Inc. | COM | 25,864 | $1.33M | 0.4% | – | – | History |
| PDDPDD Holdings Inc. | SPONSORED ADS | 8,174 | $1.09M | 0.4% | – | – | History |
| RUBYRubius Therapeutics, Inc. | COM | 12,791 | $339.0K | 0.1% | – | – | History |